| The endogenous cannabinoid system controls extinction of aversive memories G Marsicano, CT Wotjak, SC Azad, T Bisogno, G Rammes, MG Cascio, ... Nature 418 (6897), 530-534, 2002 | 2063 | 2002 |
| Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide T Bisogno, L Hanuš, L De Petrocellis, S Tchilibon, DE Ponde, I Brandi, ... British journal of pharmacology 134 (4), 845-852, 2001 | 1326 | 2001 |
| An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors SM Huang, T Bisogno, M Trevisani, A Al-Hayani, L De Petrocellis, F Fezza, ... Proceedings of the National Academy of Sciences 99 (12), 8400-8405, 2002 | 1221 | 2002 |
| Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain T Bisogno, F Howell, G Williams, A Minassi, MG Cascio, A Ligresti, ... The Journal of cell biology 163 (3), 463-468, 2003 | 1190 | 2003 |
| Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes L De Petrocellis, A Ligresti, AS Moriello, M Allarà, T Bisogno, S Petrosino, ... British journal of pharmacology 163 (7), 1479-1494, 2011 | 1009 | 2011 |
| Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action V Di Marzo, D Melck, T Bisogno, L De Petrocellis Trends in neurosciences 21 (12), 521-528, 1998 | 993 | 1998 |
| An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity S Ben-Shabat, E Fride, T Sheskin, T Tamiri, MH Rhee, Z Vogel, T Bisogno, ... European journal of pharmacology 353 (1), 23-31, 1998 | 752 | 1998 |
| The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation L De Petrocellis, D Melck, A Palmisano, T Bisogno, C Laezza, M Bifulco, ... Proceedings of the National Academy of Sciences 95 (14), 8375-8380, 1998 | 545 | 1998 |
| N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo T BISOGNO, D MELCK, MY BOBROV, NM GRETSKAYA, VV BEZUGLOV, ... Biochemical Journal 351 (3), 817-824, 2000 | 492 | 2000 |
| Endocannabinoids control spasticity in a multiple sclerosis model D Baker, G Pryce, JL Croxford, P Brown, RG Pertwee, A Makriyannis, ... The FASEB journal 15 (2), 300-302, 2001 | 488 | 2001 |
| Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes T Bisogno, S Maurelli, D Melck, L De Petrocellis, V Di Marzo Journal of Biological Chemistry 272 (6), 3315-3323, 1997 | 441 | 1997 |
| N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia CJ Chu, SM Huang, L De Petrocellis, T Bisogno, SA Ewing, JD Miller, ... Journal of Biological Chemistry 278 (16), 13633-13639, 2003 | 430 | 2003 |
| Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like … L De Petrocellis, T Bisogno, JB Davis, RG Pertwee, V Di Marzo FEBS letters 483 (1), 52-56, 2000 | 415 | 2000 |
| The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism L De Petrocellis, T Bisogno, M Maccarrone, JB Davis, A Finazzi-Agrò, ... Journal of Biological Chemistry 276 (16), 12856-12863, 2001 | 404 | 2001 |
| Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson’s disease V Di Marzo, MP HILL, T BISOGNO, AR CROSSMAN, JM BROTCHIE The FASEB Journal 14 (10), 1432-1438, 2000 | 390 | 2000 |
| Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages V Di Marzo, T Bisogno, L De Petrocellis, D Melck, P Orlando, JA Wagner, ... European Journal of Biochemistry 264 (1), 258-267, 1999 | 353 | 1999 |
| Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain SM Huang, T Bisogno, TJ Petros, SY Chang, PA Zavitsanos, RE Zipkin, ... Journal of Biological Chemistry 276 (46), 42639-42644, 2001 | 351 | 2001 |
| Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells T BISOGNO, S Nunzio, D MELCK, S MAURELLI, L De PETROCELLIS, ... Biochemical Journal 322 (2), 671-677, 1997 | 345 | 1997 |
| Possible endocannabinoid control of colorectal cancer growth A Ligresti, T Bisogno, I Matias, L De Petrocellis, MG Cascio, V Cosenza, ... Gastroenterology 125 (3), 677-687, 2003 | 342 | 2003 |
| Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both … S Maione, T Bisogno, V de Novellis, E Palazzo, L Cristino, M Valenti, ... Journal of Pharmacology and Experimental Therapeutics 316 (3), 969-982, 2006 | 320 | 2006 |
